miR-126 functions as a tumour suppressor in human gastric cancerRunhua Feng, Zhenggang Zhu, Xuehua Chen et al.|Cancer Letters|2010Cited by 298
Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IPPu Li, Zhenggang Zhu, Bingya Liu et al.|PLoS ONE|2013Cited by 76
Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative ChemotherapyWei Xu, Qianchen Ma, Lingquan Wang et al.|Frontiers in Oncology|2021Cited by 16
A Phase III Trial of Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal MetastasisSheng Lu, Zhenggang Zhu, Zhongyin Yang et al.|Future Oncology|2022Cited by 16
Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patientsRunhua Feng, Zhenggang Zhu, Birendra Kumar Sah et al.|Cancer Biomarkers|2017Cited by 15